Search Results

Medtronic's 5-Year ClosureFast Study Results Published

February 10, 2015—Medtronic plc announced that data demonstrating that the company’s ClosureFast endovenous radiofrequency ablation catheter is safe and effective for the treatment of chronic venous insufficiency (CVI) over 5 years were published by Professor Thomas Proebstle, MD, et al in the British Journal of Surgery (2015;102;212–218).

Five-Year Results Announced From Covidien's ClosureFast Study in Patients With Lower Limb Venous Disease

December 20, 2012—Covidien (Mansfield, MA) announced the 5-year results of the ClosureFast long-term European multicenter study in patients with chronic venous insufficiency.

One-Year Postmarket eSCOPE Data Support Sapheon's VenaSeal Closure System

February 28, 2014—Sapheon, Inc. (Morrisville, NC) announced 1-year results from its European multicenter clinical study of the VenaSeal Sapheon closure system for the treatment of varicose veins caused by venous reflux disease.

Medtronic's VenaSeal Closure System Evaluated in Patients With Venous Reflux Disease

April 28, 2016—Medtronic plc announced new clinical data for the VenaSeal closure system demonstrating consistent long-term durability and improved quality of life in patients with venous reflux disease.

Data Support Covidien's Vnus ClosureFast Catheter

January 17, 2011—Covidien (Mansfield, MA) announced that results from a prospective, multicenter study using the company's Vnus ClosureFast catheter demonstrated clinical efficacy and improvement in quality of life for patients treated for varicose veins.

VeClose Study Demonstrates Safety, Effectiveness of Covidien's VenaSeal Closure System

November 13, 2014—Covidien announced that the 6-month results of the VeClose pivotal study demonstrated the safety and effectiveness of the VenaSeal closure system in patients with chronic venous insufficiency having symptomatic reflux in the great saphenous vein.